Alemtuzumab [alemtuzumab]
topical
123
- Terms
-
Campath
Campath 1G
Campath 1H
Campath 1M
Lemtrada
-
Campath
Campath 1G
Campath 1H
Campath 1M
Campath-1-G
Campath-1G
Campath-1H
Campath-1M
Lemtrada
MabCambath
Monoclonal Antibody Campath-1H
Persistent link
https://www.medvik.cz/link/D000074323
Definition
An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY.
- DUI
- D000074323 MeSH Browser
- CUI
- M0253968
- History note
- 2018 (1995)
- Public note
- 2018; ALEMTUZUMAB was indexed under ANTIBODIES, MONOCLONAL, 1995-2011 and under ANTIBODIES, MONOCLONAL, HUMANIZED, 2012-2017
Allowable subheadings
- AD
- administration & dosage 24
- AE
- adverse effects 23
- AN
- analysis
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CH
- chemistry
- CL
- classification
- DE
- drug effects
- EC
- economics 1
- GE
- genetics
- HI
- history
- IM
- immunology 1
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 2
- PD
- pharmacology 20
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- TU
- therapeutic use 48
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs